During the progression of bladder cancer from low (pTa, pT1, and pT2) to higher more aggressive (pT3 and pT4) grades, f-TRPV2 and s-TRPV2 expression levels increased and decreased, respectively [1]. Here, TRPV2 is linked to urinary bladder cancer.